Design, Optimization, and Structural Characterization of an Apoptosis-Inducing Factor Peptide Targeting Human Cyclophilin A to Inhibit Apoptosis Inducing Factor-Mediated Cell Death

J Med Chem. 2021 Aug 12;64(15):11445-11459. doi: 10.1021/acs.jmedchem.1c00777. Epub 2021 Aug 2.

Abstract

Blocking the interaction between the apoptosis-inducing factor (AIF) and cyclophilin A (CypA) by the AIF fragment AIF(370-394) is protective against glutamate-induced neuronal cell death and brain injury in mice. Starting from AIF(370-394), we report the generation of the disulfide-bridged and shorter variant AIF(381-389) and its structural characterization by nuclear magnetic resonance (NMR) in the free and CypA-bound state. AIF(381-389) in both the free and bound states assumes a β-hairpin conformation similar to that of the fragment in the AIF protein and shows a highly reduced conformational flexibility. This peptide displays a similar in vitro affinity for CypA, an improved antiapoptotic activity in cells and an enhanced proteolytic stability compared to the parent peptide. The NMR-based 3D model of the AIF(381-389)/CypA complex provides a better understanding of the binding hot spots on both the peptide and the protein and can be exploited to design AIF/CypA inhibitors with improved pharmacokinetic and pharmacodynamics features.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Apoptosis Inducing Factor / chemical synthesis
  • Apoptosis Inducing Factor / chemistry
  • Apoptosis Inducing Factor / pharmacology*
  • Brain Injuries / drug therapy*
  • Cell Death / drug effects*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cyclophilin A / antagonists & inhibitors*
  • Cyclophilin A / metabolism
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Glutamic Acid / metabolism
  • Humans
  • Mice
  • Molecular Structure
  • Structure-Activity Relationship

Substances

  • Apoptosis Inducing Factor
  • Glutamic Acid
  • Cyclophilin A